Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
Chia Yin ChongRina Y-L OngValerie X-F SeahNatalie W-H TanMei-Yoke ChanShui-Yen SohChristina OngAshley S LimKoh-Cheng ThoonPublished in: Journal of paediatrics and child health (2019)
TCS usage was highly successful in CLABSI reduction by 80% in all patients, 90% in H/O and 70% in GI patients. In patients with high baseline CLABSI rates, TCS is an effective catheter-lock therapy to reduce CLABSI rates in paediatric patients.